| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 10 |
| 1 | AMBRISENTAN | 9 |
| 2 | SILDENAFIL CITRATE | 9 |
| 3 | TREPROSTINIL | 8 |
| 4 | ACETAMINOPHEN | 5 |
| 5 | ALBUTEROL SULFATE | 5 |
| 6 | FUROSEMIDE | 5 |
| 7 | SACUBITRIL AND VALSARTAN | 5 |
| 8 | ADALIMUMAB | 4 |
| 9 | ASPIRIN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 1 | BETAINE | 1 | 0.0010 |
| 2 | MIGLUSTAT | 1 | 0.0009 |
| 3 | IDURSULFASE | 3 | 0.0008 |
| 4 | MINERAL OIL | 1 | 0.0007 |
| 5 | PROPAFENONE | 2 | 0.0005 |
| 6 | NEOMYCIN OINTMENT | 1 | 0.0004 |
| 7 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 8 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 9 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Methylating Agent [EPC] | 1 | 0.0010 |
| 1 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 5 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 8 | Prostacycline Vasodilator [EPC] | 10 | 0.0001 |
| 9 | Endothelin Receptor Antagonist [EPC] | 13 | 0.0001 |